Inactive Instrument
Progenics Pharmaceuticals, Inc. Share Price
Stocks
US7431871067
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
David Mims
CEO | Chief Executive Officer | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/20/19 | Issuer sale | Chief Operating Officer | 2,94,166 | 0.3397% | ||
| 19/20/19 | Issuer sale | Executive/Senior Manager | 8,09,760 | 0.9351% | ||
| 19/20/19 | Issuer sale | Chief Executive Officer | 56,393 | 0.0651% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +1.49% | - | - | 36Cr | ||
| +1.03% | +2.30% | +54.92% | +111.78% | 5.56TCr | ||
| +2.72% | +3.06% | +53.28% | +47.85% | 4.35TCr | ||
| +1.09% | +2.84% | -13.66% | -17.49% | 2.26TCr | ||
| +1.16% | +3.45% | +0.61% | +399.85% | 2.1TCr | ||
| +3.81% | -4.13% | +16.62% | -30.70% | 1.58TCr | ||
| +0.15% | +0.50% | +9.10% | -40.04% | 1.53TCr | ||
| -0.59% | +0.80% | +27.14% | +178.26% | 1.34TCr | ||
| +5.27% | +6.41% | +21.05% | - | 1.17TCr | ||
| +1.61% | +1.17% | +90.79% | +212.97% | 1.1TCr | ||
| Average | +1.61% | +0.26% | +28.87% | +107.81% | 2.33TCr | |
| Weighted average by Cap. | +1.69% | +1.60% | +33.74% | +100.50% |
Employees
-
















